NasdaqGM:MNKDBiotechsMannKind Corporation's (NASDAQ:MNKD) Intrinsic Value Is Potentially 68% Above Its Share PriceJanuary 27, 2023Key Insights MannKind's estimated fair value is US$8.9 based on 2 Stage Free Cash Flow to Equity Current share price of...
NasdaqGS:HOWLBiotechsWerewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth PlansJanuary 27, 2023We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
NasdaqCM:MDXGBiotechsMore money in the bank for insiders who divested US$1.7m worth of MiMedx Group, Inc. (NASDAQ:MDXG) shares last yearJanuary 27, 2023Despite the fact that MiMedx Group, Inc. (NASDAQ:MDXG) stock rose 12% last week, insiders who sold US$1.7m worth of...
NasdaqGM:ARDXBiotechsBullish Ardelyx, Inc. (NASDAQ:ARDX) insiders were rewarded last week as their US$1.0m investment inflated to US$1.9mJanuary 26, 2023Ardelyx, Inc. ( NASDAQ:ARDX ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...
NasdaqGS:SGENBiotechsSeagen Inc.'s (NASDAQ:SGEN) large institutional owners must be happy as stock continues to impress, up 4.6% over the past weekJanuary 26, 2023Key Insights Significantly high institutional ownership implies Seagen's stock prices are sensitive to their trading...
NasdaqGS:BNTXBiotechsWith EPS Growth And More, BioNTech (NASDAQ:BNTX) Makes An Interesting CaseJanuary 26, 2023For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
NasdaqGS:RXDXBiotechsPrometheus Biosciences' Investors Sitting On Solid 262% Return Over YearJanuary 26, 2023Unless you borrow money to invest, the potential losses are limited. But if you pick the right stock, you can make a...
NasdaqGS:XLOBiotechsInstitutions profited after Xilio Therapeutics, Inc.'s (NASDAQ:XLO) market cap rose US$33m last week butprivate equity firms profited the mostJanuary 26, 2023If you want to know who really controls Xilio Therapeutics, Inc. ( NASDAQ:XLO ), then you'll have to look at the makeup...
NasdaqGM:INABBiotechsIs IN8bio (NASDAQ:INAB) In A Good Position To Invest In Growth?January 26, 2023We can readily understand why investors are attracted to unprofitable companies. For example, although...
NasdaqGS:ABSIBiotechsFollowing 27% Rise Last Week, Absci Shareholders Still Down 49% Over Past YearJanuary 26, 2023Absci Corporation ( NASDAQ:ABSI ) shareholders will doubtless be very grateful to see the share price up 50% in the...
NasdaqGS:MGNXBiotechsHere's Why MacroGenics (NASDAQ:MGNX) Must Use Its Cash WiselyJanuary 25, 2023Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
NasdaqGM:GRNABiotechsPrivate equity firms are GreenLight Biosciences Holdings' (NASDAQ:GRNA) biggest owners and were hit after market cap dropped US$21mJanuary 25, 2023Key Insights Significant control over GreenLight Biosciences Holdings by vc/pe firms implies that this group likely has...
NasdaqCM:IKTBiotechsCan Inhibikase Therapeutics (NASDAQ:IKT) Afford To Invest In Growth?January 25, 2023There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
NasdaqCM:CPRXBiotechsIs The Market Wrong About Catalyst Pharmaceuticals?January 25, 2023With its stock down 21% over the past week, it is easy to disregard Catalyst Pharmaceuticals (NASDAQ:CPRX). However, a...
NasdaqCM:EPIXBiotechsEstimating The Fair Value Of ESSA Pharma Inc. (NASDAQ:EPIX)January 25, 2023Key Insights ESSA Pharma's estimated fair value is US$3.4 based on 2 Stage Free Cash Flow to Equity Current share price...
NasdaqGS:ORICBiotechsCompanies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In GrowthJanuary 24, 2023We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
NasdaqGS:ARWRBiotechsA Look At The Intrinsic Value Of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)January 24, 2023Key Insights Arrowhead Pharmaceuticals' estimated fair value is US$31.2 based on 2 Stage Free Cash Flow to Equity...
NasdaqGS:MRNABiotechsModerna Rallies 3.3% This Week, Taking Three-Year Gains To 781%January 24, 2023For us, stock picking is in large part the hunt for the truly magnificent stocks. But when you hold the right stock for...
NasdaqGM:PRMEBiotechsWill Prime Medicine (NASDAQ:PRME) Spend Its Cash Wisely?January 24, 2023Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
NasdaqCM:BWVBiotechsHere's Why We're Not Too Worried About Blue Water Vaccines' (NASDAQ:BWV) Cash Burn SituationJanuary 24, 2023We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
NasdaqCM:AZYOBiotechsDespite recent gains, Aziyo Biologics, Inc. (NASDAQ:AZYO) insiders are still down US$3.0k after purchasing last yearJanuary 24, 2023Insiders who bought US$146k worth of Aziyo Biologics, Inc. ( NASDAQ:AZYO ) stock in the last year recovered part of...
NasdaqCM:VKTXBiotechsDespite Viking Therapeutics, Inc.'s recent decline, insiders have made a around US$269k profit after buying earlier this year.January 24, 2023Viking Therapeutics, Inc. ( NASDAQ:VKTX ) insiders who acquired shares over the previous 12 months, can probably afford...
NasdaqGS:BCRXBiotechsWhen Will BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Become Profitable?January 24, 2023BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) is possibly approaching a major achievement in its business, so we would...
NasdaqGS:RXRXBiotechsInsiders Relieved After Selling Recursion Pharmaceuticals With 5.1% Price DipJanuary 24, 2023By selling US$164k worth of Recursion Pharmaceuticals, Inc. ( NASDAQ:RXRX ) stock at an average sell price of US$8.77...